Mark Cuban Is Disrupting Health Care, and That's a Good Prescription (Audio: Podcast)

IPI Resident Scholar Dr. Merrill Matthews explains to IPI President Tom Giovanetti how Mark Cuban Cost Plus Drugs could provide much needed disruption in the market for generic prescription drugs.